Thursday, October 15, 2020 12:49:42 PM
I'll Alert you of stocks to Buy,
before the Run happens !
_________________________________________________________________
Good Morning Mr.___________
Thank you for your e-mail.
Per your request below, we can only confirm
what has been made public and can therefore
only confirm that certain patents were assigned
by UNB to DarkPulse as reported in the SEC filings.
https://www.sec.gov/Archives/edgar/data/866439/000168316820001905/darkpulse_10k-123119.htm)
It is our general understanding that certain filings
are normally required in order to update ownership
records at the patent office, and that the assignee
is the one that normally takes care of such filings.
Other questions should be taken up directly with DarkPulse.
Regards,
Shane
Shane Nason
Intellectual Property Manager
Office of Research Services, UNB
T: (506) 648-5995
e-mail: nasons@unb.ca
_________________________________________________________________
_________________________________________________________________
https://www.otcmarkets.com/stock/DPLS/disclosure
FORM 10-K
For the fiscal year ended December 31, 2019
https://www.otcmarkets.com/filing/html?id=14206834&guid=Nav6UKnUE8O2A3h
________________________________________________________________
________________________________________________________________
________________________________________________________________
Live! Charts
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
_________________________________________________________________
Live! Chart
Recent DPLS News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:56:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 07:14:41 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/18/2023 09:39:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:18:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 05:00:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:16:05 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 05:55:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:11 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 11/07/2023 09:29:36 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/20/2023 09:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 12:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 07:51:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/22/2023 08:41:26 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/31/2023 09:19:17 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:32:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 08:10:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 06:32:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/18/2023 09:16:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/06/2023 06:21:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM